1887

Abstract

The expression of major histocompatibility complex class I (MHC-I) molecules at the cell surface was down-regulated in BC-3 cells infected with Kaposi’s sarcoma-associated herpesvirus (KSHV)/human herpesvirus-8 at early times after treatment with 12--tetradecanoylphorbol acetate (TPA), and in HeLa cells transfected with the K5 gene of KSHV. However, an immunoprecipitation study on these cells with anti-MHC-I monoclonal antibody revealed that there was no significant reduction in the synthesis of MHC-I molecules. A pulse–chase analysis followed by endoglycosidase H digestion also demonstrated the stability and transport of MHC-I molecules from the endoplasmic reticulum to at least the medial-Golgi. K5 antigen was clearly detected by immunohistological examination of samples from Kaposi’s sarcoma, primary effusion lymphoma and Castleman’s disease. These results suggest that the down-regulation of MHC-I molecules by K5 gene expression during reactivation may be important for evading immunological surveillance in the host.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-82-5-1175
2001-05-01
2020-01-23
Loading full text...

Full text loading...

/deliver/fulltext/jgv/82/5/0821175a.html?itemId=/content/journal/jgv/10.1099/0022-1317-82-5-1175&mimeType=html&fmt=ahah

References

  1. Ahn, K., Angulo, A., Ghazal, P., Peterson, P. A., Yang, Y. & Fruh, K. ( 1996; ). Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proceedings of the National Academy of Sciences, USA 93, 10990-10995.[CrossRef]
    [Google Scholar]
  2. Andersson, M., Paabo, S., Nilsson, T. & Peterson, P. A. ( 1985; ). Impaired intracellular transport of Class I MHC antigens as a possible means for adenovirus to evade immune surveillance. Cell 43, 215-222.[CrossRef]
    [Google Scholar]
  3. Arvanitakis, L., Mesri, E. A., Nador, R. G., Said, J. W., Asch, A. S., Knowles, D. M. & Cesarman, E. ( 1996; ). Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi’s sarcoma-associated herpesvirus (KHSV/HHV-8) in the absence of Epstein–Barr virus. Blood 88, 2648-2654.
    [Google Scholar]
  4. Burgert, H.-G. & Kvist, S. ( 1985; ). An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 41, 987-997.[CrossRef]
    [Google Scholar]
  5. Campbell, A. E. & Slater, J. S. ( 1994; ). Down-regulation of major histocompatibility complex class I synthesis by murine cytomegalovirus early gene expression. Journal of Virology 68, 1805-1811.
    [Google Scholar]
  6. Cesarman, E., Chang, Y., Moore, P. S., Said, J. W. & Knowles, D. M. ( 1995; ). Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. New England Journal of Medicine 332, 1186-1191.[CrossRef]
    [Google Scholar]
  7. Coscoy, L. & Ganem, D. ( 2000; ). Kaposi’s sarcoma associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proceedings of the National Academy of Sciences, USA 97, 8051-8056.[CrossRef]
    [Google Scholar]
  8. Gao, S. J., Kingsley, L., Li, M., Zheng, W., Parravicini, C., Ziegler, J., Newton, R., Rinaldo, C. R., Saah, A., Phair, J., Detels, R., Chang, Y. & Moore, P. S. ( 1996; ). KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi’s sarcoma. Nature Medicine 2, 925-928.[CrossRef]
    [Google Scholar]
  9. Haque, M., Chen, J., Ueda, K., Mori, Y., Nakano, K., Hirata, Y., Kanamori, S., Uchiyama, Y., Inagi, R., Okuno, T. & Yamanishi, K. ( 2000; ). Identification and analysis of the K5 gene of Kaposi’s sarcoma-associated herpesvirus. Journal of Virology 74, 2867-2875.[CrossRef]
    [Google Scholar]
  10. Ishido, S., Wang, C., Lee, B.-S., Cohen, G. B. & Jung, J. U. ( 2000; ). Downregulation of major histocompatibility complex class I molecules by Kaposi’s sarcoma-associated herpesvirus K3 and K5 proteins. Journal of Virology 74, 5300-5309.[CrossRef]
    [Google Scholar]
  11. Jennings, S. R., Rice, P. L., Kloszewski, E. D., Anderson, R. W., Thompson, D. L. & Tevethia, S. S. ( 1985; ). Effect of herpes simplex virus types 1 and 2 on surface expression of class I major histocompatibility complex antigens on infected cells. Journal of Virology 56, 757-766.
    [Google Scholar]
  12. Jones, T. R., Wiertz, E. J. H. J., Fish, K. N., Nelson, J. A. & Ploegh, D. L. ( 1996; ). Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proceedings of the National Academy of Sciences, USA 93, 11327-11333.[CrossRef]
    [Google Scholar]
  13. Lehner, P. J., Karttunen, J. T., Wilkinson, G. W. G. & Cresswell, P. ( 1997; ). The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proceedings of the National Academy of Sciences, USA 94, 6904-6909.[CrossRef]
    [Google Scholar]
  14. Miller, G., Rigsby, M. O., Heston, L., Grogan, E., Sun, R., Metroka, C., Levy, J. A., Gao, S. J., Chang, Y. & Moore, P. ( 1996; ). Antibodies to butyrate-inducible antigens of Kaposi’s sarcoma-associated herpesvirus in patients with HIV-1 infection. New England Journal of Medicine 334, 1292-1297.[CrossRef]
    [Google Scholar]
  15. Miller, G., Heston, L., Grogan, E., Gradoville, L., Rigsby, M., Sun, R., Shedd, D., Kushnaryov, V. M., Grossberg, S. & Chang, Y. ( 1997; ). Selective switch between latency and lytic replication of Kaposi’s sarcoma herpesvirus and Epstein–Barr virus in dually infected body cavity lymphoma cells. Journal of Virology 71, 314-324.
    [Google Scholar]
  16. Moore, P. S., Gao, S. J., Dominguez, G., Cesarman, E., Lungu, O., Knowles, D. M., Garber, R., McGeoch, D. J., Pellet, P. & Chang, Y. ( 1996; ). Primary characterization of a herpesvirus-like agent associated with Kaposi’s sarcoma. Journal of Virology 70, 549-558.
    [Google Scholar]
  17. Parravicini, C., Chandran, B., Corbellino, M., Berti, E., Paulli, M., Moore, P. S. & Chang, Y. ( 2000; ). Differential viral protein expression in Kaposi’s sarcoma-associated herpesvirus-infected diseases: Kaposi’s sarcoma, primary effusion lymphoma, and multicentric Castleman’s disease. American Journal of Pathology 156, 743-749.[CrossRef]
    [Google Scholar]
  18. Ploegh, H. L. ( 1998; ). Viral strategies of immune evasion. Science 280, 248-253.[CrossRef]
    [Google Scholar]
  19. Renne, R., Zhong, W., Herndier, B., McGrath, M., Abbey, N., Kedes, D. & Ganem, D. ( 1996; ). Lytic growth of Kaposi’s sarcoma associated herpesvirus (human herpesvirus 8) in culture. Nature Medicine 2, 342-346.[CrossRef]
    [Google Scholar]
  20. Schwartz, O., Marechal, V., Gall, S. L., Lemonnier, F. & Heard, J.-M. ( 1996; ). Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nature Medicine 2, 338-342.[CrossRef]
    [Google Scholar]
  21. Simpson, G. R., Schulz, T. F., Whitby, D., Cook, P. M., Boshoff, C., Rainbow, L., Howard, M. R., Gao, S. J., Bohenzky, R. A., Simmonds, P., Lee, C., de Ruiter, A., Hatzakis, A., Tedder, R. S., Weller, I. V., Weiss, R. A. & Moore, P. S. ( 1996; ). Prevalence of Kaposi’s associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 348, 1133-1138.[CrossRef]
    [Google Scholar]
  22. Soulier, J., Grollet, L., Oksenhendler, E., Cacoub, P., Cazalas-Hatem, D., Babinet, P., d’Agay, M. F., Clauvel, J. P., Raphael, M., Degos, L. & Sigaux, F. ( 1995; ). Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease. Blood 86, 1276-1280.
    [Google Scholar]
  23. Wiertz, E. J. H. J., Jones, T. R., Sun, L., Bogyo, M., Geuze, H. J. & Ploegh, H. L. ( 1996; ). The human cytomegalovirus US 11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84, 769-779.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-82-5-1175
Loading
/content/journal/jgv/10.1099/0022-1317-82-5-1175
Loading

Data & Media loading...

Most cited articles

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error